acebiome

AceBiome is a microbiome company based in South Korea specializing in weight management probiotics. The company spun out of Bioneer Corporation in 2017 with the mission to improve the lives of overweight people and the quality of life through probiotic products. The company has grown rapidly with its BNRThin brand in the dietary supplement industry. The flagship probiotic strain of the company is Lactobacillus gasseri BNR17(“BNR17”), which is the first probiotic strain approved by the MFDS (Korea FDA) as a functional ingredient to help reduce body fat in addition to intestinal health. The proprietary strain and its product BNRThin have won premier awards, including NutraIngredients Awards in weight management ingredients and probiotics products. Bioneer and AceBiome have researched the strain for about two decades and have proven to help reduce body fat and relieve irritable bowel syndrome through clinical studies. AceBiome has recently expanded its horizon of the product portfolio beyond probiotics. It added a joint health supplement and a balm product under the "AnaParactin" brand, incorporating Andrographolide named “ParActin”, a plant extract of Andrographis paniculata. On the research side, the AceBiome R&D team has been building its sizable probiotic strain bank with extensive research, and several next-generation probiotic strains are in the pipeline.

Biocera Co., Ltd

Our company, BIOCERA Co. Ltd which founded in 1994, has been continually developing the new materials such as Antimicrobials, Nano Photocatalyst and Bio Ceramic Ball which are using to clean the water and air. We are also proud of having a long time accumulated high technology and know-how for manufacturing Antimicrobials, Photo-catalyst, Purifying and Alkaline water filtration backed by R & D.Recently.

ChunLab, Inc.

Founded in 2009 at Seoul National University in S. Korea, ChunLab has grown to become a leader in bioinformatics for the microbiology sector with over 350 organizations using ChunLab’s services worldwide. ChunLab’s suite of tools – web-based analysis platform, highly curated genomic databases, and optimized pipelines -- are essential for deciphering and making sense of complex biological data derived from next generation sequencing (NGS). ChunLab maintains and provides a database for taxonomy, 16S, genomes, and microbiome at www.ezbiocloud.net, which has become a must-tool for academic research and commercial development. It has been cited over 5,400 times. ChunLab's uniqueness lies in our intuitive cloud based bioinformatics platform, www.BIOiPLUG.com, which allows researchers to effectively visualize, analyze, manage and share their NGS data -- anytime and anywhere. BIOiPLUG is easy to navigate for even those with little knowledge of computer programming or bioinformatics, meaning researchers can refocus their time and efforts back into their research. Furthermore, enhanced by ChunLab's manually curated databases, users can compare thousands of precompiles genomics or microbiome datasets to get a more comprehensive analysis. ChunLab is a private venture backed company ($17 million USD) by several venture capitals as well as leading companies in the industry such as Green Cross Corp (Korean pharmaceutical) and Life River (Chinese molecular diagnostics). These funds have enabled us to speed up our R&D to develop new products and services that aim at “Making Bioinformatics Easy” in the area of the microbiome and infectious diseases.

BioSensor Laboratories, Inc.

BioSensor Laboratories, Inc., a biotech startup based in Korea, introduces an innovative TDD(Transdermal Drug Delivery) technology applicable to both fields of cosmetics and pharmaceuticals. Our technology which goes by the brand of ‘Tissue X’ has made possible a professional dermatological procedure thorough a small sized patch. Tissue X is an innovative technology in that macromolecules that couldn’t be delivered to the epidermis(inner skin) by conventional cosmetics - such as hyaluronic acid(HA) and Argireline - can be successfully and stably delivered. Also API's that could be delivered only through subcutaneous injection such as exenatide and teriparatide can now be delivered through this small sized patch. Biosensor Lab is also developing an electro-chemistry POCT(Point of Care Testing) technology that provides an effective sensor solution to pool management and food safety.

Biock

With the combination of the best bio-technologies on the planet, your ever-evolving personal health data and the blockchain, Biock is on a mission to help you -- the people -- to disrupt healthcare forever. We place users and patients into the driver seat of healthcare ecosystem innovation. Here are the keys: World-Class Biotech A global network of companies with the most advanced gene & cell analysis technologies on the planet, to help you maximize your biomedical data. Your Biock Record ® An app that makes managing your health and health information as easy as checking email, without sacrificing the security healthcare records demand. Biomedical Data Profits Control, own, optimize and monetize your personal health data, from the genes and cells stored in the Biock Bank ® to the “everyday” data you create. You-Centered Healthcare, Anywhere You are highly informed about your health. You get second and third opinions from providers worldwide. Your “hospital” is now virtual. Say hello to precision medicine. Trading Red Tape For Blockchain Efficiency. Transparency. Anonymity. Security. Solutions design for the future yet flexible enough to integrate with current systems used by healthcare service providers.